These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 21521301)
21. Immunoanalysis indicates that the sodium iodide symporter is not overexpressed in intracellular compartments in thyroid and breast cancers. Peyrottes I; Navarro V; Ondo-Mendez A; Marcellin D; Bellanger L; Marsault R; Lindenthal S; Ettore F; Darcourt J; Pourcher T Eur J Endocrinol; 2009 Feb; 160(2):215-25. PubMed ID: 19029227 [TBL] [Abstract][Full Text] [Related]
22. Clinical Manifestations and Gene Expression in Patients with Conventional Papillary Thyroid Carcinoma Carrying the BRAF(V600E) Mutation and BRAF Pseudogene. Lin JD; Fu SS; Chen JY; Lee CH; Chau WK; Cheng CW; Wang YH; Lin YF; Fang WF; Tang KT Thyroid; 2016 May; 26(5):691-704. PubMed ID: 26914762 [TBL] [Abstract][Full Text] [Related]
23. The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer. Riesco-Eizaguirre G; Rodríguez I; De la Vieja A; Costamagna E; Carrasco N; Nistal M; Santisteban P Cancer Res; 2009 Nov; 69(21):8317-25. PubMed ID: 19861538 [TBL] [Abstract][Full Text] [Related]
29. Benign nonfunctioning thyroid adenomas are characterized by a defective targeting to cell membrane or a reduced expression of the sodium iodide symporter protein. Tonacchera M; Viacava P; Agretti P; de Marco G; Perri A; di Cosmo C; de Servi M; Miccoli P; Lippi F; Naccarato AG; Pinchera A; Chiovato L; Vitti P J Clin Endocrinol Metab; 2002 Jan; 87(1):352-7. PubMed ID: 11788674 [TBL] [Abstract][Full Text] [Related]
31. Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas. Park HJ; Kim JY; Park KY; Gong G; Hong SJ; Ahn IM Thyroid; 2000 Mar; 10(3):211-7. PubMed ID: 10779135 [TBL] [Abstract][Full Text] [Related]
32. Sodium-iodide symporter (NIS) gene expression in lymph-node metastases of papillary thyroid carcinomas. Arturi F; Russo D; Giuffrida D; Schlumberger M; Filetti S Eur J Endocrinol; 2000 Nov; 143(5):623-7. PubMed ID: 11078986 [TBL] [Abstract][Full Text] [Related]
33. Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas. Saito T; Endo T; Kawaguchi A; Ikeda M; Katoh R; Kawaoi A; Muramatsu A; Onaya T J Clin Invest; 1998 Apr; 101(7):1296-300. PubMed ID: 9525971 [TBL] [Abstract][Full Text] [Related]
34. Detection of mRNA of sodium iodide symporter in benign and malignant human thyroid tissues. Liou MJ; Lin JD; Chan EC; Liu FH; Chao TC; Weng HF Cancer Lett; 2000 Nov; 160(1):75-80. PubMed ID: 11098087 [TBL] [Abstract][Full Text] [Related]
35. Low expression of sodium iodide symporter identifies aggressive thyroid tumors. Ward LS; Santarosa PL; Granja F; da Assumpção LV; Savoldi M; Goldman GH Cancer Lett; 2003 Oct; 200(1):85-91. PubMed ID: 14550956 [TBL] [Abstract][Full Text] [Related]
37. Pre-operative role of BRAF in the guidance of the surgical approach and prognosis of differentiated thyroid carcinoma. Danilovic DL; Lima EU; Domingues RB; Brandão LG; Hoff AO; Marui S Eur J Endocrinol; 2014 Apr; 170(4):619-25. PubMed ID: 24468978 [TBL] [Abstract][Full Text] [Related]
38. NADPH Oxidase NOX4 Is a Critical Mediator of BRAF Azouzi N; Cailloux J; Cazarin JM; Knauf JA; Cracchiolo J; Al Ghuzlan A; Hartl D; Polak M; Carré A; El Mzibri M; Filali-Maltouf A; Al Bouzidi A; Schlumberger M; Fagin JA; Ameziane-El-Hassani R; Dupuy C Antioxid Redox Signal; 2017 May; 26(15):864-877. PubMed ID: 27401113 [TBL] [Abstract][Full Text] [Related]
39. Expression of cAMP response element-binding protein and sodium iodide symporter in benign non-functioning and malignant thyroid tumours. Luciani P; Buci L; Conforti B; Tonacchera M; Agretti P; Elisei R; Vivaldi A; Cioppi F; Biliotti G; Manca G; Vitti P; Serio M; Peri A Eur J Endocrinol; 2003 May; 148(5):579-86. PubMed ID: 12720543 [TBL] [Abstract][Full Text] [Related]
40. High prevalence of BRAF mutation in a Brazilian cohort of patients with sporadic papillary thyroid carcinomas: correlation with more aggressive phenotype and decreased expression of iodide-metabolizing genes. Oler G; Cerutti JM Cancer; 2009 Mar; 115(5):972-80. PubMed ID: 19152441 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]